XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Common Stock
Surplus
Retained Earnings
Accumulated Other Comprehensive (Loss) Gain
Total
Balance at Dec. 31, 2020 $ 177,434 $ 3,765,406 $ 657,451 $ 47,589 $ 4,647,880
Balance (in shares) at Dec. 31, 2020 70,973,477        
Increase (Decrease) in Stockholders' Equity          
Net income     146,949   146,949
Other comprehensive Income (loss), net of tax effects       (48,620) (48,620)
Total comprehensive income (loss)         98,329
Cash dividends declared on common stock per share     (33,380)   (33,380)
Cash dividends equivalents paid on restricted stock units     (68)   (68)
Stock options exercised $ 94 1,677     1,771
Stock options exercised (in shares) 37,854        
Stock issued pursuant to restricted stock units $ 149 (149)      
Stock issued pursuant to restricted stock units (in shares) 59,462        
Common stock repurchased $ (26) (778)     (804)
Common stock repurchased (in shares) (10,347)        
Share-based compensation expense   6,092     6,092
Balance at Mar. 31, 2021 $ 177,651 3,772,248 770,952 (1,031) 4,719,820
Balance (in shares) at Mar. 31, 2021 71,060,446        
Balance at Dec. 31, 2021 $ 173,331 3,653,098 997,657 (21,146) $ 4,802,940
Balance (in shares) at Dec. 31, 2021 69,332,297       69,332,297
Increase (Decrease) in Stockholders' Equity          
Net income     100,329   $ 100,329
Other comprehensive Income (loss), net of tax effects       (272,810) (272,810)
Total comprehensive income (loss)         (172,481)
Cash dividends declared on common stock per share     (33,822)   (33,822)
Cash dividends equivalents paid on restricted stock units     (100)   (100)
Stock options exercised $ 24 384     408
Stock options exercised (in shares) 9,703        
Stock issued pursuant to restricted stock units $ 321 (321)      
Stock issued pursuant to restricted stock units (in shares) 128,302        
Common stock repurchased - buyback plan $ (2,530) (83,928)     (86,458)
Common stock repurchased - buyback plan (in shares) (1,012,038)        
Common stock repurchased $ (70) (2,287)     (2,357)
Common stock repurchased (in shares) (28,049)        
Share-based compensation expense   8,486     8,486
Common stock issued for acquisition $ 18,327 641,445     659,772
Common stock issued for acquisition (in shares) 7,330,803        
Net fair value of unvested equity awards assumed in the Atlantic Capital acquisition   (1,980)     (1,980)
Balance at Mar. 31, 2022 $ 189,403 $ 4,214,897 $ 1,064,064 $ (293,956) $ 5,174,408
Balance (in shares) at Mar. 31, 2022 75,761,018       75,761,018